About: http://webisa.webdatacommons.org/228330888

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Interestingly, there does not appear to be any cross-resistance to any of the non-nucleoside reverse transcriptase inhibitors such as efavirenz.
http://www.w3.org/ns/prov#wasQuotedFrom	natap.org